Effect of HER2 status on risk of recurrence in women with small, node-negative breast tumours

Small HER2-positive, node-negative breast cancer: who should receive systemic adjuvant treatment?

(2010) M. Joerger et al.   ANNALS OF ONCOLOGY

Management of small HER2-positive breast cancers

(2010) Susana Banerjee et al.   LANCET ONCOLOGY

Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

(2009) V. Kataja et al.   ANNALS OF ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

(2009) Yeon Hee Park et al.   BREAST CANCER RESEARCH AND TREATMENT

High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller

(2009) Ana M. Gonzalez-Angulo et al.   JOURNAL OF CLINICAL ONCOLOGY